In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability

التفاصيل البيبلوغرافية
العنوان: In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability
المؤلفون: Cinzia Borghese, Naike Casagrande, Donatella Aldinucci
المصدر: Haematologica
بيانات النشر: Ferrata Storti Foundation (Haematologica), 2021.
سنة النشر: 2021
مصطلحات موضوعية: Receptors, CCR5, business.industry, DNA damage, HIV Infections, Hematology, CCR5 receptor antagonist, Hodgkin Disease, Maraviroc, chemistry.chemical_compound, chemistry, CCR5 Receptor Antagonists, Classical Hodgkin lymphoma, Cancer research, Humans, Medicine, Letters to the Editor, business, Tumor stroma, Trabectedin, DNA Damage, medicine.drug
تدمد: 1592-8721
0390-6078
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e00e2babe397935e62690459a21209dTest
https://doi.org/10.3324/haematol.2021.279389Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....3e00e2babe397935e62690459a21209d
قاعدة البيانات: OpenAIRE